189 related articles for article (PubMed ID: 17523303)
1. Hepatic encephalopathy due to TIPS--retrospective study.
Stefánková J; Hůleki P; Babu A; Cermáková E; Safka V; Stefanek J; Fejfar T; Krajina A
Hepatogastroenterology; 2007 Mar; 54(74):480-4. PubMed ID: 17523303
[TBL] [Abstract][Full Text] [Related]
2. [Hepatic encephalopathy after TIPS--retrospective study].
Stefánková J; Fejfar T; Safka V; Hůlek P; Krajina A; Fendrichová M
Vnitr Lek; 2002 May; 48(5):390-5. PubMed ID: 12061205
[TBL] [Abstract][Full Text] [Related]
3. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
4. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
Masson S; Mardini HA; Rose JD; Record CO
QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
[TBL] [Abstract][Full Text] [Related]
5. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
[TBL] [Abstract][Full Text] [Related]
6. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
7. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
Deng D; Liao MS; Qin JP; Li XA
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
[TBL] [Abstract][Full Text] [Related]
8. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.
Somberg KA; Riegler JL; LaBerge JM; Doherty-Simor MM; Bachetti P; Roberts JP; Lake JR
Am J Gastroenterol; 1995 Apr; 90(4):549-55. PubMed ID: 7717309
[TBL] [Abstract][Full Text] [Related]
9. Critical flicker frequency as a marker of hepatic encephalopathy in patients before and after transjugular intrahepatic portosystemic shunt.
Biecker E; Hausdörfer I; Grünhage F; Strunk H; Sauerbruch T
Digestion; 2011; 83(1-2):24-31. PubMed ID: 20847560
[TBL] [Abstract][Full Text] [Related]
10. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
11. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
[TBL] [Abstract][Full Text] [Related]
14. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
[TBL] [Abstract][Full Text] [Related]
15. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.
Stewart CA; Malinchoc M; Kim WR; Kamath PS
Liver Transpl; 2007 Oct; 13(10):1366-71. PubMed ID: 17520742
[TBL] [Abstract][Full Text] [Related]
16. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.
Zuckerman DA; Darcy MD; Bocchini TP; Hildebolt CF
AJR Am J Roentgenol; 1997 Dec; 169(6):1727-31. PubMed ID: 9393198
[TBL] [Abstract][Full Text] [Related]
17. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
Kim JJ; Dasika NL; Yu E; Fontana RJ
J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
[TBL] [Abstract][Full Text] [Related]
18. Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report.
Wróblewski T; Rowiński O; Ziarkiewicz-Wróblewska B; Górnicka B; Albrecht J; Jones EA; Krawczyk M
Transplant Proc; 2006; 38(1):204-8. PubMed ID: 16504703
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.
Yin X; Zhang F; Xiao J; Wang Y; He Q; Zhu H; Leng X; Zou X; Zhang M; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1264-1269. PubMed ID: 31136318
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
